RNA-U6 small nuclear 833 as a potential drug target or biomarker

Target Name: RNU6-833P

NCBI ID: G106481444

RNU6-833P

Other Name(s): RNA, U6 small nuclear 833, pseudogene

RNA-U6 small nuclear 833 as a potential drug target or biomarker

RNA-U6 small nuclear 833 (Ru833) is a RNA molecule that has been identified as a potential drug target or biomarker in various diseases, including cancer. It is a 22-mer RNA molecule that is composed of seven exons, each encoding a unique protein gene. The gene for Ru833 is located on chromosome 6, specifically at position 833.

Ru833 is a small nuclear RNA molecule, which means it is associated with the nuclear envelope and is involved in the regulation of gene expression. It is expressed in various tissues and cells of the body, including the brain, heart, and gastrointestinal tract.

One of the reasons why Ru833 is considered a potential drug target is its unique structure. Unlike most proteins, Ru833 is not a linear molecule, but rather a circular shape with a diameter of approximately 20 amino acids. This non-linear structure makes it difficult to predict its structure-activity relationships, which can be important for the development of new drugs.

Another potential reason why Ru833 is a drug target is its involvement in various diseases, including cancer. Many studies have suggested that Ru833 is involved in the regulation of cell growth, apoptosis (programmed cell death), and inflammation. In addition, Ru833 has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that it may be a useful biomarker for the diagnosis and treatment of these diseases.

Finally, Ru833 may also be a potential drug target because it is expressed in various tissues of the body and can be easily isolated and purified. This makes it possible to study its properties and determine its potential as a drug.

In conclusion, RNA-U6 small nuclear 833 is a promising drug target or biomarker due to its unique structure and its involvement in various diseases. Further research is needed to fully understand its properties and its potential as a drug.

Protein Name: RNA, U6 Small Nuclear 833, Pseudogene

The "RNU6-833P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU6-833P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets